What is ABOS (ABOS) stock price today?

ABOS (ABOS) is currently trading at $2.92, up 2.46% today.

What is ABOS P/E ratio?

ABOS's P/E ratio is -1.17. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ABOS return on equity (ROE)?

ABOS's return on equity (ROE) is -172.86%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is ABOS's market cap?

ABOS has a market capitalization of $210.90M.

NASDAQ · Biotechnology

ABOS (ABOS) Stock

$2.92 +2.46% NASDAQ: ABOS Healthcare

Valuation

Metric	Value
Price	$2.92
Market Cap	$210.90M
P/E Ratio	-1.17
P/B Ratio	2.03
P/S Ratio	0.00
EPS (TTM)	$-2.00
52-Week High	$3.60
52-Week Low	$1.10
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-172.86%
ROA	-98.37%
ROCE	-174.65%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.16
Current Ratio	4.07

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-20.0M	$-45.0M	$-61.0M	$-114.0M	$-124.0M
Net Profit	$-101.0M	$-43.0M	$-52.0M	$-102.0M	$-121.0M
EPS	$-2.63	$-1.06	$-1.08	$-1.71	$-2.00
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$230.0M	$197.0M	$310.0M	$239.0M	$123.0M
Total Liabilities	$5.0M	$8.0M	$43.0M	$57.0M	$52.0M
Cash	$122.0M	$130.0M	$67.0M	$36.0M	$54.0M
Borrowings	$0	$0	$28.0M	$30.0M	$31.0M

Latest News

All You Need to Know About Acumen Pharmaceuticals (ABOS) Rating Upgrade to Buy Zacks · Jul 15, 2026 Acumen Pharmaceuticals Shows Early Alzheimer’s Disease Insights Exec Edge · Jul 15, 2026 Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year? Zacks · Jul 15, 2026 Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026 GlobeNewswire · Jul 15, 2026 Acumen Pharmaceuticals and Unlearn Collaborate to Explore Analyses of Alzheimer's Disease Clinical Programs ACCESS Newswire · Jul 9, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-18.0M	$-35.0M	$-43.0M	$-86.0M	$-116.0M
Investing Cash Flow	$-104.0M	$39.0M	$-172.0M	$48.0M	$134.0M
Financing Cash Flow	$2.0M	$0	$0	$0	$0
Net Cash Flow	$78.0M	$8.0M	$-63.0M	$-31.0M	$18.0M
Free Cash Flow	$-18.0M	$-35.0M	$-43.0M	$-86.0M	$-116.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-74.15%
Quick Ratio	4.55
Interest Coverage	-31.00
Return 1Y	69.80%
Return 3Y	-59.71%
Return 5Y	-85.38%

Ownership

Insiders Held6.80%

Institutions Held64.20%

Institutions Float Held68.88%

Institutional Holder	Shares	Report Date
RA Capital Management, L.P.	20,992,669	2026-03-31
Sands Capital Alternatives, LLC	3,720,105	2026-03-31
Alyeska Investment Group, L.p.	2,454,754	2026-03-31
Franklin Resources, Inc.	2,305,096	2026-03-31
Adar1 Capital Management, LLC	2,156,334	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACTU	$1.54	+1.32%	-2.73	$36.85M	0.00%
AGEN	$7.99	+4.99%	3.04	$332.72M	0.00%
ALEC	$2.40	+6.19%	-1.58	$266.46M	0.00%
FATE	$2.43	+1.67%	-1.62	$283.24M	0.00%
INO	$1.33	+4.72%	-2.73	$91.89M	0.00%

About ABOS

ABOS is led by CEO Daniel J. O'Connell, employs 61 people, headquartered in US, publicly traded since 2021.

ABOS stock trades at $2.92 with a market capitalization of $210.90M. The stock is valued at a price-to-earnings (P/E) ratio of -1.17, price-to-book of 2.03, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.10 and $3.60, and currently trades 18.9% below its 52-week high.

On profitability, ABOS generates a return on equity (ROE) of -172.86%, return on capital employed of -174.65%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides